{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:14Z","timestamp":1792715894312,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017065","name":"University of Michigan Rogel Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaccao.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:30:36Z","timestamp":1792524636000},"page":"555-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors"],"prefix":"10.1016","volume":"8","author":[{"given":"Anis","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexi","family":"Vasbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Bobby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenna","family":"de Bever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0558-0190","authenticated-orcid":false,"given":"Aidan","family":"Vosooghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pena-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujay","family":"Kalathoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Elangovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Skibniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonimarie","family":"Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-0593","authenticated-orcid":false,"given":"Theresa","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pennelope","family":"Kunkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Leja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0180-349X","authenticated-orcid":false,"given":"Salim S.","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2026.07.012_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.07.012_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib3","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","article-title":"Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis","volume":"391","author":"Moslehi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2026.07.012_bib6","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaccao.2026.07.012_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaccao.2022.11.004","article-title":"Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor-induced myocarditis","volume":"4","author":"Vasbinder","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib8","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jaccao.2026.07.012_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"85","author":"Drazner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib10","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2159-8290.CD-22-1180","article-title":"Abatacept\/Ruxolitinib and screening for concomitant respiratory muscle failure to mitigate fatality of immune-checkpoint inhibitor myocarditis","volume":"13","author":"Salem","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jaccao.2026.07.012_bib12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jamacardio.2021.2241","article-title":"Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor-associated myocarditis: a narrative review","volume":"6","author":"Lehmann","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11886-023-01915-5","article-title":"Role of biomarkers in the management of immune-checkpoint inhibitor-related myocarditis","volume":"25","author":"Vasbinder","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jaccao.2026.07.012_bib14","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1373\/clinchem.2016.255109","article-title":"Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care","volume":"63","author":"Apple","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaccao.2026.07.012_bib16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/clinchem\/41.12.1710","article-title":"Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue","volume":"41","author":"Bodor","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaccao.2026.07.012_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.CIR.88.1.101","article-title":"Cardiac troponin I. A marker with high specificity for cardiac injury","volume":"88","author":"Adams","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.07.012_bib18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1309\/8KCL-UQRF-6EEL-36XK","article-title":"Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle","volume":"114","author":"Messner","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib19","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac troponins: from myocardial infarction to chronic disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"14","key":"10.1016\/j.jaccao.2026.07.012_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2018.01.070","article-title":"Elevated cardiac troponin T in patients with skeletal myopathies","volume":"71","author":"Schmid","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib21","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.121.058489","article-title":"Skeletal muscle disorders: a noncardiac source of cardiac troponin T","volume":"145","author":"du Fay de Lavallaz","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.07.012_bib22","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0735-1097(02)02608-6","article-title":"Cardiac troponins in renal insufficiency: review and clinical implications","volume":"40","author":"Freda","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/clinchem\/41.2.312","article-title":"Discordance between results for serum troponin T and troponin I in renal disease","volume":"41","author":"Bhayana","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaccao.2026.07.012_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clinbiochem.2019.12.016","article-title":"Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac examination (ACE) 3 study","volume":"78","author":"Tveit","year":"2020","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jaccao.2026.07.012_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.118.035898","article-title":"Immune checkpoint inhibitor-associated myositis: expanding the spectrum of cardiac complications of the immunotherapy revolution","volume":"138","author":"Anquetil","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.07.012_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145186","article-title":"Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms","volume":"131","author":"Moslehi","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaccao.2026.07.012_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40264-023-01320-5","article-title":"Cardiovascular toxicity of immune checkpoint inhibitors: a guide for clinicians","volume":"46","author":"Raschi","year":"2023","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaccao.2026.07.012_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaccao.2025.02.005","article-title":"Immune checkpoint inhibitor-related myocarditis with or without concomitant myopathy: clinical findings and cardiovascular outcomes","volume":"7","author":"Itzhaki Ben Zadok","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib29","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00415-023-12134-x","article-title":"Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series","volume":"271","author":"Vicino","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/CIRCULATIONAHA.123.062405","article-title":"Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis","volume":"148","author":"Lehmann","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.07.012_bib31","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","author":"Jaffe","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jaccao.2026.07.012_bib32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s40266-025-01252-y","article-title":"Sarcopenia and cachexia in older patients with cancer: pathophysiology, diagnosis, impact on outcomes, and management strategies","volume":"42","author":"Papadopoulos","year":"2025","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jaccao.2026.07.012_bib33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.21873\/cdp.10479","article-title":"Asymptomatic troponin elevation and early mortality following immune checkpoint inhibitor therapy in patients without cardiac adverse events","volume":"5","author":"Shibutani","year":"2025","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.jaccao.2026.07.012_bib34","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.123.065988","article-title":"Cardiac troponins for diagnosis and prognostic assessment of immune checkpoint inhibitor myocarditis and myositis: the emerging importance of peripheral vision","volume":"148","author":"deFilippi","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2026.07.012_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaccao.2024.07.001","article-title":"Cardiac troponin I and T in ICI myocarditis screening, diagnosis, and prognosis","volume":"6","author":"Barac","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115186","article-title":"Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T","volume":"216","author":"Tomsitz","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaccao.2026.07.012_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jaccao.2025.06.009","article-title":"Cardiac troponin screening and clinical outcomes in patients receiving immunotherapy","volume":"7","author":"Cheng","year":"2025","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/clinchem\/hvaf077","article-title":"Exploring the role of cardiac troponin-specific autoantibodies: prolonged cardiac troponin elimination, reduced clearance, and variable interference across 5 commercial assays","volume":"71","author":"Salonen","year":"2025","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaccao.2026.07.012_bib39","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/CIRCULATIONAHA.125.076296","article-title":"Troponin autoantibodies, macrotroponin, and assay interference","volume":"152","author":"Wittfooth","year":"2025","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccao.2026.07.012_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaccao.2023.10.008","article-title":"Impact of the ESC cardio-oncology guidelines biomarker criteria on incidence of cancer therapy-related cardiac dysfunction","volume":"6","author":"Mecinaj","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccao.2026.07.012_bib41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jaccao.2024.07.010","article-title":"Preventing cardiac damage in patients treated for breast cancer and lymphoma: the PROACT clinical trial","volume":"6","author":"Austin","year":"2024","journal-title":"JACC CardioOncol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087326002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:42:51Z","timestamp":1792712571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087326002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666087326002966"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.07.012","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}